• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫显性源于相互竞争的细胞毒性T淋巴细胞(CTL)之间的功能差异。

Immunodomination results from functional differences between competing CTL.

作者信息

Roy-Proulx G, Meunier M C, Lanteigne A M, Brochu S, Perreault C

机构信息

Guy-Bernier Research Center, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada.

出版信息

Eur J Immunol. 2001 Aug;31(8):2284-92. doi: 10.1002/1521-4141(200108)31:8<2284::aid-immu2284>3.0.co;2-e.

DOI:10.1002/1521-4141(200108)31:8<2284::aid-immu2284>3.0.co;2-e
PMID:11477540
Abstract

The presence of dominant epitopes suppresses generation of CTL activity toward other non-dominant epitopes found on the same antigen-presenting cell (APC). This phenomenon, termed immunodomination, drastically restricts the diversity of the repertoire of CTL responses. Under various experimental conditions we assessed the in vivo expansion by tetramer staining and function by expression of O-glycans and intracellular perforin of CTL specific for a dominant (B6(dom1)) and a non-dominant (HY) H2D(b)-restricted epitope. Immunodomination abrogated expansion rather than differentiation of HY-specific CTL. When immunodomination was precluded because HY was presented alone or because high numbers of antigen-bearing APC were present, the numbers of HY-specific T cells detected after antigen priming were similar to those of B6(dom1)-specific T cells. The main difference between T cells that recognized B6(dom1) versus HY was functional rather than quantitative. The key feature of T cells specific for B6(dom1) is that they show striking up-regulation of molecules involved in CTL effector activity rather than accumulating to particularly high levels, as assessed by tetramer staining. These results support the emerging concept that following antigen priming, CTL populations of similar size can display important differences in effector function, and suggest that these functional differences are instrumental in shaping the repertoire of CTL responses.

摘要

优势表位的存在会抑制针对同一抗原呈递细胞(APC)上其他非优势表位的CTL活性的产生。这种现象被称为免疫显性,它极大地限制了CTL反应库的多样性。在各种实验条件下,我们通过四聚体染色评估了体内扩增情况,并通过O-聚糖的表达和CTL特异性针对优势(B6(dom1))和非优势(HY)H2D(b)限制性表位的细胞内穿孔素的表达来评估其功能。免疫显性消除了HY特异性CTL的扩增而非分化。当由于单独呈现HY或由于存在大量携带抗原的APC而排除免疫显性时,抗原激发后检测到的HY特异性T细胞数量与B6(dom1)特异性T细胞数量相似。识别B6(dom1)与HY的T细胞之间的主要差异在于功能而非数量。B6(dom1)特异性T细胞的关键特征是,通过四聚体染色评估,它们显示出参与CTL效应活性的分子显著上调,而不是积累到特别高的水平。这些结果支持了一个新出现的概念,即抗原激发后,大小相似的CTL群体在效应功能上可能存在重要差异,并表明这些功能差异有助于塑造CTL反应库。

相似文献

1
Immunodomination results from functional differences between competing CTL.免疫显性源于相互竞争的细胞毒性T淋巴细胞(CTL)之间的功能差异。
Eur J Immunol. 2001 Aug;31(8):2284-92. doi: 10.1002/1521-4141(200108)31:8<2284::aid-immu2284>3.0.co;2-e.
2
Characterization of the Fas ligand/Fas-dependent apoptosis of antiretroviral, class I MHC tetramer-defined, CD8+ CTL by in vivo retrovirus-infected cells.体内逆转录病毒感染细胞对Fas配体/Fas依赖性凋亡的特征分析,该凋亡由抗逆转录病毒的、I类主要组织相容性复合体四聚体定义的CD8+细胞毒性T淋巴细胞介导。
J Immunol. 2002 Mar 15;168(6):2751-8. doi: 10.4049/jimmunol.168.6.2751.
3
Shaping the repertoire of cytotoxic T-lymphocyte responses: explanation for the immunodominance effect whereby cytotoxic T lymphocytes specific for immunodominant antigens prevent recognition of nondominant antigens.塑造细胞毒性T淋巴细胞反应库:对免疫显性效应的解释,即针对免疫显性抗原的细胞毒性T淋巴细胞会阻止对非显性抗原的识别。
Blood. 1999 Feb 1;93(3):952-62.
4
Cytotoxic T cells reactive to an immunodominant leukemia-associated antigen can be specifically primed and expanded by combining a specific priming step with nonspecific large-scale expansion.通过将特定的致敏步骤与非特异性大规模扩增相结合,可特异性启动并扩增对免疫显性白血病相关抗原产生反应的细胞毒性T细胞。
J Immunother. 2008 Feb-Mar;31(2):121-31. doi: 10.1097/CJI.0b013e31815aaf24.
5
On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens.关于细胞毒性T淋巴细胞对次要组织相容性抗原反应中免疫显性的机制
Eur J Immunol. 1997 Feb;27(2):421-30. doi: 10.1002/eji.1830270212.
6
The in vivo fate of APCs displaying minor H antigen and/or MHC differences is regulated by CTLs specific for immunodominant class I-associated epitopes.展示次要组织相容性抗原和/或主要组织相容性复合体差异的抗原呈递细胞的体内命运,由针对免疫显性的I类相关表位的细胞毒性T淋巴细胞调控。
J Immunol. 1999 Dec 15;163(12):6462-7.
7
In vivo cross-presentation of a soluble protein antigen: kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes.可溶性蛋白抗原的体内交叉呈递:识别显性和隐性表位的效应性细胞毒性T淋巴细胞的动力学、分布及产生
J Immunol. 2000 Dec 1;165(11):6123-32. doi: 10.4049/jimmunol.165.11.6123.
8
Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.肿瘤特异性细胞毒性T淋巴细胞(CTL)在体外利用穿孔素和Fas配体介导的细胞溶解作用杀伤小鼠肾癌细胞,但在体内,在没有穿孔素的情况下也能使肿瘤消退。
J Immunol. 2002 Apr 1;168(7):3484-92. doi: 10.4049/jimmunol.168.7.3484.
9
The immunodominant, Ld-restricted T cell response to hepatitis B surface antigen (HBsAg) efficiently suppresses T cell priming to multiple Dd-, Kd-, and Kb-restricted HBsAg epitopes.针对乙型肝炎表面抗原(HBsAg)的免疫显性、Ld限制的T细胞应答可有效抑制T细胞对多种Dd、Kd和Kb限制的HBsAg表位的启动。
J Immunol. 2002 Jun 15;168(12):6253-62. doi: 10.4049/jimmunol.168.12.6253.
10
Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanisms.病毒感染的肝细胞对穿孔素依赖的细胞毒性T淋巴细胞(CTL)效应机制具有抗性。
J Immunol. 2001 Aug 1;167(3):1566-74. doi: 10.4049/jimmunol.167.3.1566.

引用本文的文献

1
A natural polymorphism of Mycobacterium tuberculosis in the esxH gene disrupts immunodomination by the TB10.4-specific CD8 T cell response.结核分枝杆菌 esxH 基因的自然多态性破坏了 TB10.4 特异性 CD8 T 细胞应答的免疫优势。
PLoS Pathog. 2020 Oct 19;16(10):e1009000. doi: 10.1371/journal.ppat.1009000. eCollection 2020 Oct.
2
Deletion of naïve T cells recognizing the minor histocompatibility antigen HY with toxin-coupled peptide-MHC class I tetramers inhibits cognate CTL responses and alters immunodominance.用毒素偶联肽-MHC Ⅰ类四聚体删除识别次要组织相容性抗原 HY 的幼稚 T 细胞可抑制同源 CTL 反应并改变免疫优势。
Transpl Immunol. 2013 Dec;29(1-4):138-45. doi: 10.1016/j.trim.2013.10.005. Epub 2013 Oct 23.
3
Broadening of the T-cell repertoire to HIV-1 Gag p24 by vaccination of HLA-A2/DR transgenic mice with overlapping peptides in the CAF05 adjuvant.
用 CAF05 佐剂进行重叠肽疫苗接种,拓宽 HLA-A2/DR 转基因小鼠针对 HIV-1 Gag p24 的 T 细胞 repertoire。
PLoS One. 2013 May 17;8(5):e63575. doi: 10.1371/journal.pone.0063575. Print 2013.
4
Fragmentation of SIV-gag vaccine induces broader T cell responses.SIV-gag 疫苗的碎裂可诱导更广泛的 T 细胞反应。
PLoS One. 2012;7(10):e48038. doi: 10.1371/journal.pone.0048038. Epub 2012 Oct 31.
5
CD8+ T-cell cross-competition is governed by peptide-MHC class I stability.CD8+ T 细胞交叉竞争受肽-MHC Ⅰ类稳定性的控制。
Eur J Immunol. 2012 Jan;42(1):256-63. doi: 10.1002/eji.201142010. Epub 2011 Nov 28.
6
A theory of immunodominance and adaptive regulation.免疫优势与适应性调节理论。
Bull Math Biol. 2011 Jul;73(7):1645-65. doi: 10.1007/s11538-010-9585-5. Epub 2010 Oct 1.
7
Dominant CD8+ T-lymphocyte responses suppress expansion of vaccine-elicited subdominant T lymphocytes in rhesus monkeys challenged with pathogenic simian-human immunodeficiency virus.在受到致病性猿猴-人类免疫缺陷病毒攻击的恒河猴中,占主导地位的CD8 + T淋巴细胞反应会抑制疫苗引发的次要T淋巴细胞的扩增。
J Virol. 2009 Oct;83(19):10028-35. doi: 10.1128/JVI.01015-09. Epub 2009 Jul 29.
8
Two host factors regulate persistence of H7-specific T cells injected in tumor-bearing mice.两个宿主因素调节注射到荷瘤小鼠体内的H7特异性T细胞的持久性。
PLoS One. 2009;4(1):e4116. doi: 10.1371/journal.pone.0004116. Epub 2009 Jan 7.
9
Naive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ T cell immunodominance.初始前体频率和MHC结合而非表位多样性程度塑造了CD8+T细胞免疫显性。
J Immunol. 2008 Aug 1;181(3):2124-33. doi: 10.4049/jimmunol.181.3.2124.
10
HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1.与艾滋病进展延迟相关的人类白细胞抗原(HLA)等位基因对初始抗HIV-1的CD8(+) T细胞反应有很大贡献。
PLoS Med. 2006 Oct;3(10):e403. doi: 10.1371/journal.pmed.0030403.